| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 41 | 2019 | 3494 | 2.260 |
Why?
|
| Genetic Linkage | 21 | 2019 | 2421 | 1.960 |
Why?
|
| Nuclear Family | 15 | 2017 | 318 | 1.880 |
Why?
|
| Family | 30 | 2019 | 3147 | 1.360 |
Why?
|
| Models, Statistical | 36 | 2012 | 5102 | 1.240 |
Why?
|
| Likelihood Functions | 19 | 2012 | 1005 | 1.150 |
Why?
|
| Genetic Predisposition to Disease | 50 | 2023 | 17446 | 1.110 |
Why?
|
| Genetic Markers | 24 | 2012 | 2634 | 1.050 |
Why?
|
| Linkage Disequilibrium | 23 | 2019 | 1997 | 0.820 |
Why?
|
| Biometry | 12 | 2009 | 558 | 0.760 |
Why?
|
| Chromosome Mapping | 13 | 2010 | 4740 | 0.740 |
Why?
|
| Longitudinal Studies | 36 | 2015 | 13989 | 0.660 |
Why?
|
| Genetics, Population | 6 | 2013 | 934 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 45 | 2017 | 15519 | 0.640 |
Why?
|
| Statistics as Topic | 7 | 2017 | 2373 | 0.630 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 12 | 2023 | 3047 | 0.620 |
Why?
|
| Data Interpretation, Statistical | 23 | 2011 | 2716 | 0.600 |
Why?
|
| Quantitative Trait Loci | 8 | 2008 | 2019 | 0.600 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 12261 | 0.590 |
Why?
|
| Phenotype | 33 | 2023 | 16365 | 0.590 |
Why?
|
| Haplotypes | 18 | 2017 | 2779 | 0.570 |
Why?
|
| Genetic Variation | 12 | 2017 | 6544 | 0.530 |
Why?
|
| Asthma | 18 | 2013 | 6011 | 0.470 |
Why?
|
| Computer Simulation | 25 | 2019 | 6196 | 0.470 |
Why?
|
| Bibliometrics | 1 | 2017 | 339 | 0.450 |
Why?
|
| Pedigree | 11 | 2019 | 4644 | 0.420 |
Why?
|
| Body Mass Index | 14 | 2011 | 12720 | 0.410 |
Why?
|
| Serpin E2 | 1 | 2011 | 48 | 0.390 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2007 | 544 | 0.390 |
Why?
|
| Genetic Testing | 11 | 2011 | 3444 | 0.380 |
Why?
|
| Genetic Techniques | 3 | 2011 | 435 | 0.370 |
Why?
|
| Smoking | 11 | 2017 | 8987 | 0.370 |
Why?
|
| Meta-Analysis as Topic | 6 | 2015 | 1344 | 0.370 |
Why?
|
| Linear Models | 16 | 2013 | 5952 | 0.360 |
Why?
|
| Gene Frequency | 20 | 2019 | 3588 | 0.350 |
Why?
|
| Bipolar Disorder | 9 | 2011 | 5027 | 0.340 |
Why?
|
| Pulmonary Emphysema | 3 | 2023 | 672 | 0.340 |
Why?
|
| Genome, Human | 15 | 2017 | 4420 | 0.330 |
Why?
|
| Clinical Trials as Topic | 24 | 2011 | 7913 | 0.330 |
Why?
|
| Environment | 4 | 2010 | 1124 | 0.330 |
Why?
|
| Genotype | 29 | 2010 | 12951 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2010 | 380 | 0.320 |
Why?
|
| Regression Analysis | 13 | 2007 | 6459 | 0.310 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 365 | 0.310 |
Why?
|
| Software | 9 | 2019 | 4443 | 0.300 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 128 | 0.300 |
Why?
|
| Algorithms | 25 | 2017 | 13881 | 0.290 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2010 | 587 | 0.290 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 2703 | 0.280 |
Why?
|
| Humans | 205 | 2023 | 744343 | 0.280 |
Why?
|
| Obesity | 16 | 2012 | 12745 | 0.280 |
Why?
|
| Survival Analysis | 7 | 2004 | 10252 | 0.280 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 296 | 0.280 |
Why?
|
| Genes | 1 | 2010 | 1893 | 0.270 |
Why?
|
| Family Relations | 1 | 2008 | 321 | 0.270 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 1432 | 0.270 |
Why?
|
| Case-Control Studies | 26 | 2014 | 21746 | 0.260 |
Why?
|
| Mass Media | 1 | 2008 | 305 | 0.260 |
Why?
|
| Body Weight | 11 | 2012 | 4669 | 0.260 |
Why?
|
| Emphysema | 2 | 2023 | 247 | 0.250 |
Why?
|
| Genetic Loci | 4 | 2017 | 2575 | 0.250 |
Why?
|
| Inheritance Patterns | 1 | 2007 | 340 | 0.250 |
Why?
|
| Biostatistics | 3 | 2011 | 162 | 0.250 |
Why?
|
| Alleles | 16 | 2017 | 6933 | 0.240 |
Why?
|
| Epidemiologic Methods | 4 | 2009 | 1364 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 460 | 0.230 |
Why?
|
| Logistic Models | 15 | 2004 | 13408 | 0.230 |
Why?
|
| Peer Group | 1 | 2008 | 635 | 0.220 |
Why?
|
| Research Design | 15 | 2017 | 5987 | 0.220 |
Why?
|
| Disease | 1 | 2008 | 680 | 0.220 |
Why?
|
| Pharmacogenetics | 3 | 2011 | 675 | 0.200 |
Why?
|
| Bulimia | 4 | 2008 | 382 | 0.190 |
Why?
|
| Multivariate Analysis | 11 | 2011 | 12245 | 0.190 |
Why?
|
| Motor Activity | 1 | 2011 | 2714 | 0.190 |
Why?
|
| Physical Examination | 1 | 2007 | 1237 | 0.190 |
Why?
|
| Sample Size | 4 | 2010 | 845 | 0.190 |
Why?
|
| Alzheimer Disease | 8 | 2008 | 8037 | 0.180 |
Why?
|
| Forced Expiratory Volume | 7 | 2015 | 1743 | 0.180 |
Why?
|
| Child | 47 | 2021 | 77709 | 0.180 |
Why?
|
| Treatment Refusal | 2 | 2000 | 421 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 7 | 2008 | 3658 | 0.180 |
Why?
|
| Enzymes | 2 | 2013 | 266 | 0.180 |
Why?
|
| Depressive Disorder | 9 | 2012 | 3748 | 0.170 |
Why?
|
| Female | 100 | 2023 | 380194 | 0.170 |
Why?
|
| Parents | 5 | 2019 | 3407 | 0.170 |
Why?
|
| Patient Dropouts | 7 | 2001 | 421 | 0.160 |
Why?
|
| Male | 90 | 2023 | 350118 | 0.160 |
Why?
|
| Analysis of Variance | 8 | 2006 | 6365 | 0.160 |
Why?
|
| Malpractice | 8 | 2004 | 572 | 0.160 |
Why?
|
| Social Isolation | 1 | 2021 | 365 | 0.160 |
Why?
|
| Bulimia Nervosa | 3 | 2012 | 177 | 0.150 |
Why?
|
| Mathematical Computing | 2 | 2001 | 147 | 0.150 |
Why?
|
| Exercise | 6 | 2011 | 5615 | 0.150 |
Why?
|
| Zidovudine | 4 | 2002 | 620 | 0.150 |
Why?
|
| Polymorphism, Genetic | 8 | 2013 | 4328 | 0.150 |
Why?
|
| Family Health | 6 | 2010 | 1282 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2015 | 374 | 0.140 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15076 | 0.140 |
Why?
|
| Siblings | 4 | 2009 | 854 | 0.140 |
Why?
|
| Therapeutics | 1 | 1996 | 116 | 0.140 |
Why?
|
| Models, Biological | 5 | 2003 | 9583 | 0.130 |
Why?
|
| School Health Services | 1 | 1999 | 375 | 0.130 |
Why?
|
| PUVA Therapy | 2 | 1994 | 98 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2008 | 3188 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2017 | 1783 | 0.130 |
Why?
|
| Gene Dosage | 3 | 2009 | 1252 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2011 | 9959 | 0.130 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 3768 | 0.130 |
Why?
|
| Bayes Theorem | 4 | 2012 | 2309 | 0.130 |
Why?
|
| Vital Capacity | 2 | 2013 | 925 | 0.130 |
Why?
|
| Environmental Exposure | 2 | 2013 | 4234 | 0.120 |
Why?
|
| Monte Carlo Method | 6 | 2008 | 1254 | 0.120 |
Why?
|
| Child Health Services | 2 | 1999 | 667 | 0.120 |
Why?
|
| Models, Theoretical | 7 | 2012 | 3589 | 0.120 |
Why?
|
| Patient Compliance | 2 | 2002 | 2684 | 0.120 |
Why?
|
| Cadherins | 2 | 2017 | 907 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1028 | 0.120 |
Why?
|
| New England | 1 | 2017 | 1022 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 171 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4462 | 0.120 |
Why?
|
| Austria | 3 | 2010 | 203 | 0.120 |
Why?
|
| Canada | 8 | 2008 | 2065 | 0.110 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1200 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2005 | 369 | 0.110 |
Why?
|
| Health Behavior | 2 | 2008 | 2636 | 0.110 |
Why?
|
| Renal Dialysis | 9 | 1983 | 1786 | 0.110 |
Why?
|
| Iatrogenic Disease | 7 | 1995 | 547 | 0.110 |
Why?
|
| Mexico | 4 | 2013 | 690 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2004 | 12354 | 0.100 |
Why?
|
| Age of Onset | 6 | 2017 | 3271 | 0.100 |
Why?
|
| alpha-Macroglobulins | 2 | 2003 | 64 | 0.100 |
Why?
|
| Mood Disorders | 3 | 2003 | 1106 | 0.100 |
Why?
|
| Probability | 8 | 2012 | 2505 | 0.090 |
Why?
|
| Nasal Decongestants | 1 | 2010 | 28 | 0.090 |
Why?
|
| Risk | 9 | 2012 | 9687 | 0.090 |
Why?
|
| Schools | 1 | 1999 | 1433 | 0.090 |
Why?
|
| Risk Factors | 30 | 2017 | 72290 | 0.090 |
Why?
|
| Middle Aged | 52 | 2017 | 213383 | 0.090 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 30 | 0.090 |
Why?
|
| Molecular Epidemiology | 1 | 2012 | 468 | 0.090 |
Why?
|
| Poverty | 2 | 2021 | 2660 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2002 | 2232 | 0.090 |
Why?
|
| Depressive Disorder, Major | 5 | 2009 | 4644 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 403 | 0.090 |
Why?
|
| Phenylephrine | 1 | 2010 | 301 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2017 | 1438 | 0.090 |
Why?
|
| Tobacco Use Disorder | 2 | 2006 | 688 | 0.090 |
Why?
|
| Ozone | 1 | 2013 | 469 | 0.090 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2009 | 89 | 0.090 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 651 | 0.090 |
Why?
|
| Least-Squares Analysis | 3 | 2001 | 379 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2915 | 0.090 |
Why?
|
| Pharmacokinetics | 1 | 2008 | 88 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 645 | 0.080 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2009 | 207 | 0.080 |
Why?
|
| Sex Factors | 9 | 2008 | 10397 | 0.080 |
Why?
|
| Principal Component Analysis | 2 | 2008 | 940 | 0.080 |
Why?
|
| Adolescent Behavior | 2 | 2008 | 1151 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2003 | 816 | 0.080 |
Why?
|
| Self Disclosure | 2 | 2007 | 251 | 0.080 |
Why?
|
| Odds Ratio | 9 | 2008 | 9849 | 0.080 |
Why?
|
| X Chromosome | 2 | 2023 | 814 | 0.080 |
Why?
|
| Prevalence | 11 | 2010 | 15226 | 0.080 |
Why?
|
| Plasmodium vivax | 1 | 2009 | 208 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 4803 | 0.080 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.080 |
Why?
|
| Malaria, Vivax | 1 | 2009 | 173 | 0.080 |
Why?
|
| Patient Care Team | 1 | 1999 | 2531 | 0.080 |
Why?
|
| Metagenomics | 1 | 2011 | 428 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1990 | 306 | 0.080 |
Why?
|
| Life Style | 1 | 1999 | 3835 | 0.070 |
Why?
|
| Confidence Intervals | 3 | 2008 | 2971 | 0.070 |
Why?
|
| Health Promotion | 1 | 1999 | 2205 | 0.070 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 497 | 0.070 |
Why?
|
| Random Allocation | 13 | 1998 | 2429 | 0.070 |
Why?
|
| Alcoholism | 3 | 2008 | 1906 | 0.070 |
Why?
|
| Lung | 6 | 2017 | 9856 | 0.070 |
Why?
|
| Adult | 50 | 2016 | 214055 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.070 |
Why?
|
| Psoriasis | 2 | 1994 | 898 | 0.070 |
Why?
|
| Television | 2 | 1999 | 409 | 0.070 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2008 | 214 | 0.070 |
Why?
|
| Weight Gain | 3 | 2009 | 2292 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 1 | 2006 | 81 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2017 | 2715 | 0.070 |
Why?
|
| Medication Errors | 3 | 1998 | 798 | 0.070 |
Why?
|
| Fibromyalgia | 2 | 2008 | 388 | 0.070 |
Why?
|
| Adolescent | 28 | 2012 | 85781 | 0.070 |
Why?
|
| Body Composition | 3 | 2006 | 2401 | 0.070 |
Why?
|
| Sampling Studies | 5 | 2002 | 623 | 0.070 |
Why?
|
| Age Factors | 12 | 2013 | 18370 | 0.070 |
Why?
|
| Cohort Studies | 11 | 2017 | 40561 | 0.070 |
Why?
|
| Mental Disorders | 5 | 2008 | 6600 | 0.070 |
Why?
|
| Dysthymic Disorder | 2 | 2002 | 74 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2003 | 462 | 0.060 |
Why?
|
| Risk-Taking | 2 | 2008 | 986 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1663 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 914 | 0.060 |
Why?
|
| Medication Systems, Hospital | 2 | 1995 | 158 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 1985 | 188 | 0.060 |
Why?
|
| Prisoners | 1 | 2007 | 297 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2006 | 338 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 245 | 0.060 |
Why?
|
| Indinavir | 1 | 2003 | 74 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 2006 | 3279 | 0.060 |
Why?
|
| Uremia | 9 | 1983 | 201 | 0.060 |
Why?
|
| Comorbidity | 7 | 2008 | 10388 | 0.060 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1987 | 547 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2015 | 5021 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2004 | 246 | 0.060 |
Why?
|
| Anorexia Nervosa | 3 | 2012 | 1286 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 595 | 0.060 |
Why?
|
| Hematopoietic System | 1 | 1983 | 109 | 0.060 |
Why?
|
| Reproducibility of Results | 7 | 2010 | 19905 | 0.060 |
Why?
|
| Anxiety Disorders | 3 | 2003 | 2690 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 604 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2009 | 7880 | 0.050 |
Why?
|
| Bone Density | 2 | 2006 | 3468 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 202 | 0.050 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 445 | 0.050 |
Why?
|
| Estrogens | 1 | 2009 | 1566 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2006 | 570 | 0.050 |
Why?
|
| Computational Biology | 1 | 2014 | 3521 | 0.050 |
Why?
|
| Blood Urea Nitrogen | 6 | 1983 | 191 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2005 | 575 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 733 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1423 | 0.050 |
Why?
|
| Panic Disorder | 1 | 2005 | 616 | 0.050 |
Why?
|
| Respiratory Sounds | 2 | 1997 | 696 | 0.050 |
Why?
|
| Erythrocyte Indices | 1 | 2002 | 146 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2014 | 299 | 0.050 |
Why?
|
| Boston | 8 | 2017 | 9313 | 0.050 |
Why?
|
| HIV Protease Inhibitors | 1 | 2003 | 430 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 871 | 0.050 |
Why?
|
| New York | 8 | 2004 | 886 | 0.050 |
Why?
|
| Aged | 28 | 2017 | 163280 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2002 | 389 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2014 | 4286 | 0.050 |
Why?
|
| Ohio | 1 | 2021 | 337 | 0.050 |
Why?
|
| Fetal Development | 1 | 2006 | 767 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 245 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2013 | 3297 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1994 | 4034 | 0.050 |
Why?
|
| Health Surveys | 5 | 2004 | 4037 | 0.040 |
Why?
|
| United States | 8 | 2012 | 69872 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2009 | 6038 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2002 | 390 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2000 | 209 | 0.040 |
Why?
|
| Exons | 2 | 2007 | 2437 | 0.040 |
Why?
|
| Baltimore | 1 | 1999 | 231 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2002 | 3508 | 0.040 |
Why?
|
| Thailand | 2 | 2009 | 296 | 0.040 |
Why?
|
| Menarche | 1 | 2001 | 516 | 0.040 |
Why?
|
| Mutation | 7 | 2021 | 29786 | 0.040 |
Why?
|
| Cross-Sectional Studies | 10 | 2012 | 25043 | 0.040 |
Why?
|
| Inpatients | 3 | 1999 | 2518 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2001 | 1643 | 0.040 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 1998 | 103 | 0.040 |
Why?
|
| Body Height | 4 | 1995 | 1577 | 0.040 |
Why?
|
| Angiotensinogen | 1 | 1999 | 163 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 1504 | 0.040 |
Why?
|
| Hospital Records | 4 | 1991 | 95 | 0.040 |
Why?
|
| Schizophrenia | 3 | 2011 | 6882 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2001 | 367 | 0.040 |
Why?
|
| Migraine Disorders | 2 | 2008 | 1620 | 0.040 |
Why?
|
| Spirometry | 2 | 2015 | 864 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2000 | 422 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2263 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2000 | 475 | 0.040 |
Why?
|
| Bronchodilator Agents | 2 | 2015 | 502 | 0.040 |
Why?
|
| Morbidity | 4 | 1991 | 1769 | 0.040 |
Why?
|
| Follow-Up Studies | 11 | 2008 | 39050 | 0.040 |
Why?
|
| Hospitals, Urban | 2 | 1997 | 499 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1270 | 0.040 |
Why?
|
| Hospitals | 4 | 1991 | 3952 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 3703 | 0.040 |
Why?
|
| Homozygote | 3 | 2011 | 1785 | 0.040 |
Why?
|
| Markov Chains | 1 | 2000 | 969 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2005 | 2052 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2001 | 536 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 1994 | 5686 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2007 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 1999 | 469 | 0.030 |
Why?
|
| Hypertension | 4 | 2001 | 8480 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2006 | 1580 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1526 | 0.030 |
Why?
|
| Risk Management | 4 | 1995 | 571 | 0.030 |
Why?
|
| Iron Regulatory Protein 2 | 1 | 2015 | 41 | 0.030 |
Why?
|
| Medical Audit | 2 | 2004 | 467 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 1998 | 2886 | 0.030 |
Why?
|
| Lod Score | 3 | 2004 | 614 | 0.030 |
Why?
|
| Medical Errors | 1 | 2004 | 1297 | 0.030 |
Why?
|
| Cohort Effect | 1 | 1995 | 39 | 0.030 |
Why?
|
| Air Pollution | 4 | 1997 | 2286 | 0.030 |
Why?
|
| Penetrance | 1 | 2017 | 381 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2012 | 63114 | 0.030 |
Why?
|
| Drug Therapy | 3 | 2010 | 497 | 0.030 |
Why?
|
| Tars | 1 | 1994 | 20 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3712 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2009 | 3046 | 0.030 |
Why?
|
| Mothers | 2 | 2021 | 2165 | 0.030 |
Why?
|
| Lipids | 1 | 2006 | 3305 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 373 | 0.030 |
Why?
|
| Systems Analysis | 1 | 1995 | 172 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2171 | 0.030 |
Why?
|
| Child Development | 1 | 1986 | 2223 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1738 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 1987 | 2282 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13102 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2803 | 0.030 |
Why?
|
| Serpins | 1 | 2015 | 247 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2006 | 1947 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2013 | 23338 | 0.030 |
Why?
|
| Introns | 2 | 2008 | 991 | 0.030 |
Why?
|
| Photochemotherapy | 2 | 1994 | 807 | 0.030 |
Why?
|
| Respiratory Function Tests | 2 | 2002 | 1616 | 0.030 |
Why?
|
| Fruit | 1 | 1999 | 1142 | 0.030 |
Why?
|
| Anti-HIV Agents | 2 | 2000 | 4256 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 46 | 0.030 |
Why?
|
| Vegetables | 1 | 1999 | 1182 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 1425 | 0.030 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2013 | 78 | 0.030 |
Why?
|
| Aging | 3 | 2009 | 8664 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2002 | 10943 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2013 | 24 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1025 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6489 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2013 | 97 | 0.030 |
Why?
|
| Hospitalization | 6 | 2004 | 10262 | 0.030 |
Why?
|
| Dietary Fats | 2 | 1999 | 2017 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 7785 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 1985 | 3966 | 0.030 |
Why?
|
| Intelligence | 1 | 1998 | 920 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2008 | 41006 | 0.030 |
Why?
|
| Psychopathology | 1 | 1995 | 409 | 0.030 |
Why?
|
| Physicians | 2 | 2006 | 4567 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2012 | 53288 | 0.030 |
Why?
|
| Incidence | 5 | 2003 | 20947 | 0.030 |
Why?
|
| Depression | 2 | 2002 | 7766 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 498 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5221 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
| Premature Birth | 1 | 2004 | 1721 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2559 | 0.030 |
Why?
|
| Perphenazine | 1 | 2011 | 34 | 0.030 |
Why?
|
| Time Factors | 6 | 2017 | 40075 | 0.020 |
Why?
|
| Physician's Role | 1 | 1998 | 943 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 103 | 0.020 |
Why?
|
| Anthropometry | 2 | 2006 | 1350 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 595 | 0.020 |
Why?
|
| Binge-Eating Disorder | 1 | 2012 | 137 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 1995 | 807 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2003 | 4386 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1462 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 213 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 2 | 1994 | 545 | 0.020 |
Why?
|
| Pregnancy | 6 | 2021 | 29144 | 0.020 |
Why?
|
| Motivation | 1 | 2000 | 1971 | 0.020 |
Why?
|
| Hospital Costs | 1 | 1997 | 985 | 0.020 |
Why?
|
| Urban Health | 1 | 2013 | 547 | 0.020 |
Why?
|
| Psychometrics | 3 | 2009 | 3002 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11524 | 0.020 |
Why?
|
| Germany | 1 | 2012 | 862 | 0.020 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 234 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
| Menopause | 2 | 2009 | 1626 | 0.020 |
Why?
|
| Anxiety | 1 | 2004 | 4297 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 437 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 1129 | 0.020 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2009 | 98 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1994 | 1060 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 535 | 0.020 |
Why?
|
| Health Services Research | 2 | 2004 | 1836 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 1998 | 1637 | 0.020 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 57776 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 257 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 1987 | 46 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 375 | 0.020 |
Why?
|
| Twin Studies as Topic | 1 | 2008 | 105 | 0.020 |
Why?
|
| Chlorpheniramine | 1 | 1987 | 13 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 801 | 0.020 |
Why?
|
| Methotrexate | 1 | 1994 | 1727 | 0.020 |
Why?
|
| Quality of Life | 1 | 2009 | 12804 | 0.020 |
Why?
|
| Education, Continuing | 1 | 2008 | 112 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2009 | 209 | 0.020 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 1987 | 57 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 1987 | 100 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1999 | 8642 | 0.020 |
Why?
|
| China | 2 | 2006 | 2248 | 0.020 |
Why?
|
| Lidocaine | 1 | 1989 | 544 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 2327 | 0.020 |
Why?
|
| Kartagener Syndrome | 1 | 1986 | 32 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9146 | 0.020 |
Why?
|
| Massachusetts | 1 | 1999 | 8663 | 0.020 |
Why?
|
| Mathematics | 3 | 1994 | 728 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2006 | 115 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 79 | 0.020 |
Why?
|
| Dietary Proteins | 3 | 1986 | 963 | 0.020 |
Why?
|
| HIV Infections | 2 | 2003 | 16718 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 42 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1758 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1989 | 789 | 0.020 |
Why?
|
| Dietary Services | 1 | 1984 | 17 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2013 | 12026 | 0.020 |
Why?
|
| Perception | 1 | 1992 | 1198 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 176 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2849 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 1990 | 1179 | 0.020 |
Why?
|
| Data Collection | 4 | 2001 | 3341 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 136 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1999 | 3923 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.020 |
Why?
|
| Reference Values | 2 | 2003 | 4982 | 0.020 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1996 | 2987 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 326 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 272 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1987 | 1032 | 0.010 |
Why?
|
| Laboratories | 1 | 1987 | 463 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1994 | 4851 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1114 | 0.010 |
Why?
|
| Length of Stay | 1 | 1997 | 6309 | 0.010 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 38 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 641 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2011 | 1708 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1982 | 74 | 0.010 |
Why?
|
| Infant | 6 | 2008 | 35136 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20129 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2004 | 367 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 798 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1983 | 163 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2005 | 5867 | 0.010 |
Why?
|
| Social Change | 1 | 2003 | 153 | 0.010 |
Why?
|
| Growth | 1 | 1984 | 376 | 0.010 |
Why?
|
| Nova Scotia | 1 | 2002 | 34 | 0.010 |
Why?
|
| Cataplexy | 1 | 2003 | 60 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1983 | 185 | 0.010 |
Why?
|
| Cilia | 1 | 1986 | 466 | 0.010 |
Why?
|
| Antipsychotic Agents | 2 | 2011 | 3057 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1983 | 211 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 279 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 274 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20822 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1983 | 346 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 1987 | 850 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 513 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 2005 | 481 | 0.010 |
Why?
|
| Minerals | 1 | 1983 | 275 | 0.010 |
Why?
|
| Hematocrit | 1 | 1983 | 636 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 658 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2187 | 0.010 |
Why?
|
| Malaria, Falciparum | 1 | 2009 | 1077 | 0.010 |
Why?
|
| Overweight | 1 | 2012 | 2371 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 109 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 154 | 0.010 |
Why?
|
| Affect | 1 | 2009 | 1476 | 0.010 |
Why?
|
| Social Environment | 1 | 2006 | 1023 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 124 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1991 | 8554 | 0.010 |
Why?
|
| Puberty | 1 | 2003 | 490 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 644 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2003 | 812 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2009 | 2455 | 0.010 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2006 | 489 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 1333 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 156 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 11725 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2009 | 1732 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2001 | 414 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2006 | 1725 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2268 | 0.010 |
Why?
|
| Europe | 1 | 2006 | 3339 | 0.010 |
Why?
|
| DNA | 2 | 2004 | 7301 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 1990 | 2212 | 0.010 |
Why?
|
| Nicotine | 1 | 2004 | 681 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2003 | 811 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1186 | 0.010 |
Why?
|
| Family Practice | 1 | 2001 | 516 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12072 | 0.010 |
Why?
|
| Genomics | 1 | 2014 | 5720 | 0.010 |
Why?
|
| Finland | 1 | 1999 | 602 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1989 | 11727 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8949 | 0.010 |
Why?
|
| beta Carotene | 1 | 1999 | 527 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 15540 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2624 | 0.010 |
Why?
|
| Eosinophils | 1 | 2002 | 955 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 2958 | 0.010 |
Why?
|
| Infant, Newborn | 5 | 2006 | 25625 | 0.010 |
Why?
|
| Retrospective Studies | 5 | 2008 | 77449 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1953 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1997 | 115 | 0.010 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 1998 | 204 | 0.010 |
Why?
|
| Platelet Count | 1 | 1999 | 781 | 0.010 |
Why?
|
| Pharmacies | 1 | 1998 | 150 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1275 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1154 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2002 | 1463 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2000 | 676 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1200 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12788 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 1859 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11031 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 4258 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1991 | 4371 | 0.010 |
Why?
|
| Animals | 3 | 2001 | 168757 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1547 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1320 | 0.010 |
Why?
|
| Vitamin E | 1 | 1999 | 869 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 3493 | 0.010 |
Why?
|
| Child Behavior | 1 | 2001 | 839 | 0.010 |
Why?
|
| Heart Diseases | 2 | 2001 | 2788 | 0.010 |
Why?
|
| Medical Records | 2 | 1991 | 1413 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6773 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2001 | 2539 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 1998 | 668 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1983 | 2072 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 29063 | 0.010 |
Why?
|
| Anemia | 1 | 1983 | 1506 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 4420 | 0.010 |
Why?
|
| Young Adult | 2 | 2009 | 56430 | 0.010 |
Why?
|
| Selection Bias | 1 | 1995 | 371 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 1790 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1881 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1983 | 4199 | 0.010 |
Why?
|
| Weight Loss | 1 | 2004 | 2622 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1983 | 2575 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2804 | 0.010 |
Why?
|
| Urban Population | 1 | 2000 | 2021 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1979 | 1504 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1681 | 0.010 |
Why?
|
| Insurance Claim Reporting | 1 | 1991 | 163 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 6993 | 0.010 |
Why?
|
| Netherlands | 1 | 1995 | 2170 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1999 | 2046 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 172 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1991 | 571 | 0.010 |
Why?
|
| Decision Support Systems, Clinical | 1 | 1998 | 1164 | 0.010 |
Why?
|
| Systole | 1 | 1991 | 958 | 0.010 |
Why?
|
| Diastole | 1 | 1991 | 791 | 0.010 |
Why?
|
| Wound Infection | 1 | 1991 | 242 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13033 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1997 | 1071 | 0.000 |
Why?
|
| Coronary Disease | 2 | 1983 | 6077 | 0.000 |
Why?
|
| Astemizole | 1 | 1987 | 2 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1999 | 2838 | 0.000 |
Why?
|
| Peer Review | 1 | 1989 | 209 | 0.000 |
Why?
|
| Mutagens | 1 | 1987 | 168 | 0.000 |
Why?
|
| Dextrocardia | 1 | 1986 | 37 | 0.000 |
Why?
|
| Dyneins | 1 | 1986 | 123 | 0.000 |
Why?
|
| Long-Term Care | 1 | 1989 | 607 | 0.000 |
Why?
|
| California | 1 | 1989 | 1402 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 351 | 0.000 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 4266 | 0.000 |
Why?
|
| Insurance Claim Review | 1 | 1990 | 720 | 0.000 |
Why?
|
| Quality Control | 1 | 1987 | 841 | 0.000 |
Why?
|
| Minority Groups | 1 | 1991 | 1223 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1991 | 1257 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1991 | 1827 | 0.000 |
Why?
|
| Skinfold Thickness | 1 | 1983 | 162 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 5751 | 0.000 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1983 | 126 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1995 | 3679 | 0.000 |
Why?
|
| Mental Health | 1 | 1995 | 3019 | 0.000 |
Why?
|
| Nutritional Requirements | 1 | 1983 | 286 | 0.000 |
Why?
|
| Disabled Persons | 1 | 1991 | 1212 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1991 | 2585 | 0.000 |
Why?
|
| Phosphates | 1 | 1983 | 786 | 0.000 |
Why?
|
| Maternal Health Services | 1 | 1984 | 455 | 0.000 |
Why?
|
| Potassium | 1 | 1983 | 1336 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2557 | 0.000 |
Why?
|
| Health Status | 1 | 1991 | 4034 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1990 | 2400 | 0.000 |
Why?
|
| Sinusitis | 1 | 1986 | 923 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1983 | 1801 | 0.000 |
Why?
|
| Eating | 1 | 1983 | 1536 | 0.000 |
Why?
|
| Creatinine | 1 | 1981 | 1919 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1991 | 4687 | 0.000 |
Why?
|
| Heart Failure | 1 | 1979 | 10900 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13695 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1990 | 14722 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1983 | 1170 | 0.000 |
Why?
|
| Calcinosis | 1 | 1983 | 1499 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 81183 | 0.000 |
Why?
|
| Mortality | 1 | 1981 | 2864 | 0.000 |
Why?
|
| Calcium | 1 | 1983 | 5756 | 0.000 |
Why?
|
| Vitamin D | 1 | 1983 | 3223 | 0.000 |
Why?
|
| Neoplasms | 1 | 1998 | 21683 | 0.000 |
Why?
|
| Diet | 1 | 1983 | 7939 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1983 | 15165 | 0.000 |
Why?
|